Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care

Por Martinelli, Erika, Morgillo, Floriana, Troiani, Teresa, Tortora, Giampaolo, Ciardiello, Fortunato
Publicado em 2007

Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

Por Morgillo, Floriana, Martinelli, Erika, Troiani, Teresa, Orditura, Michele, De Vita, Ferdinando, Ciardiello, Fortunato
Publicado em 2011

Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

Por Troiani, Teresa, Martinelli, Erika, Morgillo, Floriana, Capasso, Anna, Nappi, Anna, Sforza, Vincenzo, Ciardiello, Fortunato
Publicado em 2013

Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence

Por Troiani, Teresa, Napolitano, Stefania, Della Corte, Carminia Maria, Martini, Giulia, Martinelli, Erika, Morgillo, Floriana, Ciardiello, Fortunato
Publicado no ESMO Open (2016)

Critical appraisal of the use of regorafenib in the management of colorectal cancer

Por Festino, Lucia, Fabozzi, Alessio, Manzo, Anna, Gambardella, Valentina, Martinelli, Erika, Troiani, Teresa, De Vita, Ferdinando, Orditura, Michele, Ciardiello, Fortunato, Morgillo, Floriana
Publicado em 2013

Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass

Por Orditura, Michele, Lieto, Eva, Ferraraccio, Francesca, De Cataldis, Giuseppe, Troiani, Teresa, Castellano, Paolo, Catalano, Giuseppe, Ciardiello, Fortunato, Galizia, Gennaro, De Vita, Ferdinando
Publicado em 2007

Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer

Por Sforza, Vincenzo, Martinelli, Erika, Ciardiello, Fortunato, Gambardella, Valentina, Napolitano, Stefania, Martini, Giulia, della Corte, Carminia, Cardone, Claudia, Ferrara, Marianna L, Reginelli, Alfonso, Liguori, Giuseppina, Belli, Giulio, Troiani, Teresa
Publicado no World J Gastroenterol (2016)

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

Por De Vita, Ferdinando, Ventriglia, Jole, Febbraro, Antonio, Laterza, Maria Maddalena, Fabozzi, Alessio, Savastano, Beatrice, Petrillo, Angelica, Diana, Anna, Giordano, Guido, Troiani, Teresa, Conzo, Giovanni, Galizia, Gennaro, Ciardiello, Fortunato, Orditura, Michele
Publicado no BMC Cancer (2016)

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells

Por Della Corte, Carminia Maria, Ciaramella, Vincenza, Mauro, Concetta Di, Castellone, Maria Domenica, Papaccio, Federica, Fasano, Morena, Sasso, Ferdinando Carlo, Martinelli, Erika, Troiani, Teresa, De Vita, Ferdinando, Orditura, Michele, Bianco, Roberto, Ciardiello, Fortunato, Morgillo, Floriana
Publicado no Oncotarget (2015)

AXL is an oncotarget in human colorectal cancer

Por Martinelli, Erika, Martini, Giulia, Cardone, Claudia, Troiani, Teresa, Liguori, Giuseppina, Vitagliano, Donata, Napolitano, Stefania, Morgillo, Floriana, Rinaldi, Barbara, Melillo, Rosa Marina, Liotti, Federica, Nappi, Anna, Bianco, Roberto, Berrino, Liberato, Ciuffreda, Loreta Pia, Ciardiello, Davide, Iaffaioli, Vincenzo, Botti, Gerardo, Ferraiolo, Fiorella, Ciardiello, Fortunato
Publicado no Oncotarget (2015)